drugset / Trial / NCT01089127
Efficacy and Safety of Different Doses of Indacaterol in Chronic Obstructive Pulmonary Disease (COPD)
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study compared the 14-day bronchodilator efficacy of indacaterol with that of placebo and salmeterol.
Timeline
- Start
- 2010-03
- Primary completion
- 2010-07
- Completion
- 2010-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Indacaterol | Other / unclassified | 18.75 ug | Inhaled |
| Subject | Indacaterol | Other / unclassified | 37.5 ug | Inhaled |
| Subject | Indacaterol | Other / unclassified | 75 ug | Inhaled |
| Subject | Indacaterol | Other / unclassified | 150 ug | Inhaled |
| Comparator | Salmeterol | Other / unclassified | 50 ug | Inhaled |